Pharming Group N.V. - ADS, each representing 10 ordinary shares (PHAR)
PHAR moved a median of 0.00% 30 minutes after news, and -0.22% by the close. How PHAR actually reacts to news — the realized, point-in-time move the market made, measured across 222 labeled events over the last three years with zero look-ahead.
PHAR’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 39% | 117 |
| 30-min | 0.00% | 49% | 172 |
| 60-min | +0.06% | 51% | 189 |
| to close | -0.22% | 44% | 217 |
| Middle 50% of PHAR reactions | -0.75% to +0.83% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 222 |
Half of all Pharming Group N.V. - ADS, each representing 10 ordinary shares news events land between -0.75% and +0.83% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when PHAR moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to PHAR's baseline. Nothing else.
Recent PHAR events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K Pharming Group N.V. For: Oct 14 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +0.94% | |
| Form 6-K Pharming Group N.V. For: Sep 29 | SEC filing · Form 6-K | SEC EDGAR | -0.11% | -1.57% | |
| Pharming announces CEO transition | Press release | GlobeNewswire | -0.11% | -1.57% | |
| Form 6-K Pharming Group N.V. For: Sep 25 | SEC filing · Form 6-K | SEC EDGAR | — | -0.38% | |
| Form 6-K Pharming Group N.V. For: Sep 22 | SEC filing · Form 6-K | SEC EDGAR | +0.18% | +1.35% | |
| Form 6-K Pharming Group N.V. For: Sep 11 | SEC filing · Form 6-K | SEC EDGAR | — | +0.09% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bronstein, Gewirtz & Grossman, LLC (PHAR) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | — | -1.17% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Pharming Group N.V. (PHAR) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | +0.00% | +0.60% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pharming Group N.V. (PHAR) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | — | -0.68% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pharming Group N.V. (PHAR) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | +3.17% | |
| Form 6-K Pharming Group N.V. For: Aug 13 | SEC filing · Form 6-K | SEC EDGAR | -0.50% | +2.40% | |
| Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | +7.56% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Pharming Group N.V. (PHAR) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.00% | — | |
| Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | +1.26% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pharming Group N.V. (PHAR) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | — | -0.70% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Pharming Group N.V. (PHAR) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | -0.19% | -1.25% | |
| Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | -0.91% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pharming Group N.V. (PHAR) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.79% | -3.06% | |
| Form 6-K Pharming Group N.V. For: Jul 30 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +10.60% | |
| Form 6-K Pharming Group N.V. For: Jun 04 | SEC filing · Form 6-K | SEC EDGAR | — | +1.47% | |
| Form 6-K Pharming Group N.V. For: May 28 | SEC filing · Form 6-K | SEC EDGAR | — | -0.58% | |
| Form 6-K Pharming Group N.V. For: May 22 | SEC filing · Form 6-K | SEC EDGAR | -0.59% | +0.15% | |
| Form 6-K Pharming Group N.V. For: Mar 12 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -2.26% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pharming Group N.V. (PHAR) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | — | -0.43% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pharming Group N.V. (PHAR) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | +0.18% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Pharming Group N.V. (PHAR) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.62% | +1.37% | |
| Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +1.02% | +3.89% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Pharming Group N.V. (PHAR) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | -1.15% | |
| Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | -0.95% | |
| Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | -1.70% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pharming Group N.V. (PHAR) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.30% | -0.18% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Pharming Group N.V. (PHAR) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.25% | +0.55% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pharming Group N.V. (PHAR) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | — | -2.73% | |
| Form 6-K Pharming Group N.V. For: Feb 03 | SEC filing · Form 6-K | SEC EDGAR | -1.17% | -4.11% | |
| Form 6-K Pharming Group N.V. For: Feb 01 | SEC filing · Form 6-K | SEC EDGAR | +0.94% | +0.27% | |
| Form 6-K Pharming Group N.V. For: Jan 08 | SEC filing · Form 6-K | SEC EDGAR | +1.40% | +0.51% | |
| Form 6-K Pharming Group N.V. For: Nov 06 | SEC filing · Form 6-K | SEC EDGAR | +1.07% | -7.14% | |
| Form 6-K Pharming Group N.V. For: Oct 20 | SEC filing · Form 6-K | SEC EDGAR | — | -2.53% | |
| Form 6-K Pharming Group N.V. For: Oct 06 | SEC filing · Form 6-K | SEC EDGAR | — | -0.25% | |
| Form 6-K Pharming Group N.V. For: Oct 01 | SEC filing · Form 6-K | SEC EDGAR | +0.54% | +0.65% | |
| Form 6-K Pharming Group N.V. For: Sep 10 | SEC filing · Form 6-K | SEC EDGAR | +2.58% | -11.23% | |
| Form 6-K Pharming Group N.V. For: Sep 02 | SEC filing · Form 6-K | SEC EDGAR | +0.09% | +2.19% | |
| Form 6-K Pharming Group N.V. For: Jul 31 | SEC filing · Form 6-K | SEC EDGAR | -0.48% | -0.45% | |
| Form 6-K Pharming Group N.V. For: Jun 24 | SEC filing · Form 6-K | SEC EDGAR | — | +5.42% | |
| Form 6-K Pharming Group N.V. For: Jun 11 | SEC filing · Form 6-K | SEC EDGAR | +0.13% | +0.13% | |
| Form 6-K Pharming Group N.V. For: May 08 | SEC filing · Form 6-K | SEC EDGAR | +0.39% | -1.38% | |
| Form 6-K Pharming Group N.V. For: Apr 30 | SEC filing · Form 6-K | SEC EDGAR | — | -0.17% | |
| Form 6-K Pharming Group N.V. For: Apr 25 | SEC filing · Form 6-K | SEC EDGAR | — | -2.18% | |
| Form 6-K Pharming Group N.V. For: Apr 23 | SEC filing · Form 6-K | SEC EDGAR | +1.55% | -1.08% | |
| Form 20-F Pharming Group N.V. For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | — | -3.41% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the PHAR section they belong to.
Where else PHAR is measured.
PHAR earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Pharming Group N.V. - ADS, each representing 10 ordinary shares's median reaction calculated?
Every labeled PHAR news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 222 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of PHAR's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does PHAR's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.